Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation
- PMID: 23634718
- PMCID: PMC3643848
- DOI: 10.1186/1471-2350-14-49
Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation
Abstract
Background: Global developmental delay and mental retardation are associated with X-linked disorders including Hunter syndrome (mucopolysaccharidosis type II) and Fragile X syndrome (FXS). Single nucleotide mutations in the iduronate 2-sulfatase (IDS) gene at Xq28 most commonly cause Hunter syndrome while a CGG expansion in the FMR1 gene at Xq27.3 is associated with Fragile X syndrome. Gene deletions of the Xq27-28 region are less frequently found in either condition with rare reports in females. Additionally, an association between Xq27-28 deletions and skewed X-inactivation of the normal X chromosome observed in previous studies suggested a primary role of the Xq27-28 region in X-inactivation.
Case presentation: We describe the clinical, molecular and biochemical evaluations of a four year-old female patient with global developmental delay and a hemizygous deletion of Xq27.3q28 (144,270,614-154,845,961 bp), a 10.6 Mb region that contains >100 genes including IDS and FMR1. A literature review revealed rare cases with similar deletions that included IDS and FMR1 in females with developmental delay, variable features of Hunter syndrome, and skewed X-inactivation of the normal X chromosome. In contrast, our patient exhibited skewed X-inactivation of the deleted X chromosome and tested negative for Hunter syndrome.
Conclusions: This is a report of a female with a 10.6 Mb Xq27-28 deletion with skewed inactivation of the deleted X chromosome. Contrary to previous reports, our observations do not support a primary role of the Xq27-28 region in X-inactivation. A review of the genes in the deletion region revealed several potential genes that may contribute to the patient's developmental delays, and sequencing of the active X chromosome may provide insight into the etiology of this clinical presentation.
Figures



Similar articles
-
Generation of Induced Pluripotent Stem Cells from a Female Patient with a Xq27.3-q28 Deletion to Establish Disease Models and Identify Therapies.Cell Reprogram. 2020 Aug;22(4):179-188. doi: 10.1089/cell.2020.0012. Epub 2020 Jun 30. Cell Reprogram. 2020. PMID: 32608992 Free PMC article.
-
Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation.Am J Med Genet A. 2007 Jun 15;143A(12):1358-65. doi: 10.1002/ajmg.a.31781. Am J Med Genet A. 2007. PMID: 17506108
-
Clinical and molecular genetic characterization of two female patients harboring the Xq27.3q28 deletion with different ratios of X chromosome inactivation.Hum Mutat. 2020 Aug;41(8):1447-1460. doi: 10.1002/humu.24058. Epub 2020 Jun 19. Hum Mutat. 2020. PMID: 32485067
-
Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis.Expert Rev Mol Med. 2015 Jul 1;17:e13. doi: 10.1017/erm.2015.11. Expert Rev Mol Med. 2015. PMID: 26132880 Free PMC article. Review.
-
Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature.Am J Med Genet A. 2008 May 15;146A(10):1358-67. doi: 10.1002/ajmg.a.32261. Am J Med Genet A. 2008. PMID: 18412117 Free PMC article. Review.
Cited by
-
Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in FMR1 and Associated Phenotypes.Genes (Basel). 2021 Oct 22;12(11):1669. doi: 10.3390/genes12111669. Genes (Basel). 2021. PMID: 34828275 Free PMC article.
-
Identification of rare copy number variations reveals PJA2, APCS, SYNPO, and TAC1 as novel candidate genes in Autism Spectrum Disorders.Mol Genet Genomic Med. 2019 Aug;7(8):e786. doi: 10.1002/mgg3.786. Epub 2019 Jun 29. Mol Genet Genomic Med. 2019. PMID: 31254375 Free PMC article.
-
Microdeletions including FMR1 in three female patients with intellectual disability - further delineation of the phenotype and expression studies.Mol Syndromol. 2014 Feb;5(2):65-75. doi: 10.1159/000357962. Epub 2014 Jan 29. Mol Syndromol. 2014. PMID: 24715853 Free PMC article.
-
Identification of partial trisomy 13q in two unrelated patients using single-nucleotide polymorphism array and literature overview.Mol Cytogenet. 2022 Jul 28;15(1):31. doi: 10.1186/s13039-022-00608-y. Mol Cytogenet. 2022. PMID: 35902965 Free PMC article.
-
Generation of Induced Pluripotent Stem Cells from a Female Patient with a Xq27.3-q28 Deletion to Establish Disease Models and Identify Therapies.Cell Reprogram. 2020 Aug;22(4):179-188. doi: 10.1089/cell.2020.0012. Epub 2020 Jun 30. Cell Reprogram. 2020. PMID: 32608992 Free PMC article.
References
-
- Neufeld EF, Muenzer J. In: The Metabolic and Molecular Bases of Inherited Disease. Volume 3. 8. Scriver CR, Beaudet AL, Sly WS, Valle D, editor. New York: McGraw-Hill; 2001. The mucopolysaccharidoses; pp. 3421–3452.
-
- Timms KM, Huckett LE, Belmont JW, Shapira SK, Gibbs RA. DNA deletion confined to the iduronate-2-sulfatase promoter abolishes IDS gene expression. Hum Mutat. 1998;11:121–126. - PubMed
-
- Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen GJB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905–914. doi: 10.1016/0092-8674(91)90397-H. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous